Prosecution Insights
Last updated: October 14, 2026

Gene Friend Way Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Gene Friend Way Inc. is currently managing 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This action is being handled by 1 distinct examiner and a distinct art unit. The concentration of the current workload indicates a focused prosecution effort on a single matter. This allows the company to direct its intellectual property resources toward a specific goal within the Biotechnology & Pharmaceuticals sector. By working with a single examiner, the applicant can establish a clear line of communication and better understand the examiner's specific concerns.

FONSECA LOPEZ, FRANCINI ALVARENGA is the busiest examiner, with 1 pending office action. This examiner oversees the only active office action for the company. Consequently, the success of the current prosecution cycle depends on the interaction with this specific examiner and the standards of the single art unit involved. Because there is 1 pending office action, the applicant can provide a very detailed and targeted response. The presence of 1 pending office action with FONSECA LOPEZ, FRANCINI ALVARENGA ensures that the company's attention is not divided across multiple pending matters. This streamlined profile is conducive to a thorough and focused prosecution process.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
FONSECA LOPEZ, FRANCINI ALVARENGA 1 29.6% +37.1%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17849653 MACHINE LEARNING MODELS FOR DETERMINING PATHOGENIC GENETIC VARIANTS FONSECA LOPEZ, FRANCINI ALVARENGA —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17849653 MACHINE LEARNING MODELS FOR DETERMINING PATHOGENIC GENETIC VARIANTS FONSECA LOPEZ, FRANCINI ALVARENGA —

Top Art Units

Art UnitApps
1685 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17849653 MACHINE LEARNING MODELS FOR DETERMINING PATHOGENIC GENETIC VARIANTS FONSECA LOPEZ, FRANCINI ALVARENGA 1685 §101§103 Final Rejection — Pending Jun 26, 2022

Managing Gene Friend Way Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Gene Friend Way Inc. have?

Gene Friend Way Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Gene Friend Way Inc. applications?

Francini Alvarenga Fonseca Lopez has the most, with 1 of Gene Friend Way Inc.'s pending office actions.

What technology area are Gene Friend Way Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month